Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer-Reference-Cited by-同舟云学术

Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer

Published:2018-12 Issue:1 Volume:9 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Liu Jingyi,Duan Zhibing^ORCID,Guo Weijie,Zeng Lei,Wu Yadi,Chen Yule,Tai Fang,Wang Yifan,Lin Yiwei^ORCID,Zhang Qiang,He Yanling,Deng Jiong,Stewart Rachel L.,Wang Chi,Lin Pengnian Charles,Ghaffari Saghi,Evers B. Mark,Liu Suling,Zhou Ming-Ming,Zhou Binhua P.,Shi Jian

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-018-07258-y.pdf

Reference45 articles.

1. Bertos, N. R. & Park, M. Breast cancer - one term, many entities? J. Clin. Invest. 121, 3789–3796 (2011).

2. Polyak, K., Shipitsin, M., Campbell-Marrotta, L., Bloushtain-Qimron, N. & Park, S. Y. Breast tumor heterogeneity: causes and consequences. Breast Cancer Res. 11(Suppl 1), S18 (2009).

3. Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747–752 (2000).

4. Vargo-Gogola, T. & Rosen, J. M. Modelling breast cancer: one size does not fit all. Nat. Rev. Cancer 7, 659–672 (2007).

5. Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 490, 61–70 (2012).

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A self-assembled affibody-PROTAC conjugate nanomedicine for targeted cancer therapy;Nano Research;2024-09-07

2. Transcriptomic analyses of lung tissues reveal key genes associated with progression of systemic sclerosis-interstitial lung disease (SSc-ILD);Journal of Autoimmunity;2024-09

3. Serine/Threonine kinase 16 phosphorylates STAT3 and confers a JAK2-Inhibition resistance phenotype in triple-negative breast cancer;Biochemical Pharmacology;2024-07

4. Optimization of the Procedure for Gram Scale Synthesis of Silicon Rhodamine and its Application in Labeling BRD4 Kinase Inhibitor;Journal of Analysis and Testing;2024-05-14

5. A prismatic view of the epigenetic-metabolic regulatory axis in breast cancer therapy resistance;Oncogene;2024-05-08